Formulation development and evaluation of medicated chewing gum of anti-emetic drug
Context: Medicated chewing gum (MCG) of Domperidone Maleate (DM) was developed by direct compression method with the goal to achieve quick onset of action and to improve patient compliance. Objective: Formulation development of MCG of DM and optimization of the formulation by screening of different...
Saved in:
Main Authors: | Mansi Paradkar (Author), Balaram Gajra (Author), Bhautik Patel (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medicated chewing gums - A novel targeted drug delivery
by: Nimesh Jain, et al.
Published: (2019) -
Reye Syndrome and Anti-Emetics
by: J Gordon Millichap
Published: (1991) -
The choice of intense sweetener in the composition of medicated chewing gum under development
by: Yu. S. Maslii, et al.
Published: (2019) -
An emerging technique of medicated chewing gum in drug delivery system: a review
by: Deepika Khatiwara, et al.
Published: (2021) -
Chewing Gum on Bowel Motility
by: S. Tamilselvi, et al.
Published: (2024)